DAFTAR PUSTAKAAronoff, G.R., Brier, M.E., 2009. Practical Guidelines For Drug Dosing in Patients with Impaired Kidney Function, in: Schrier, RW: Manual of Nephrology Seventh Edition, pp: 270-96. Lippincott Williams & Wilkins, Philadelphia.

Aryanti, Y., 2009. Studi Penggunaan Obat Antihipertensi Pada Pasien Penyakit Ginjal Kronik. Fakultas Farmasi Universitas Airlangga, Surabaya.

Baharudin, J.E.A., 2011. Gambaran Penggunaan Antihipertensi Pada pasien gagal Ginjal kronik di Rumah Sakit Umum H. Adam Malik: Permasalahan Terkait Obat (skripsi). Universitas Sumatera Utara, Medan.

Biko, M., 2012. Rasionalitas Penggunaan Antihipertensi Pada Pasien Hipertensi dengan Stroke di Instalasi Rawat Inap RSUD Undata Palu Pada Tahun 2011 (skripsi). Universitas Tadulako, Palu.

Carrero, J.J., 2010. Gender Differences in Chronic Kidney Disease: Underpinnings and Therapeutic Implications. Kidney Blood Press Res. 33:383-392.

Center for Disease Control and Prevention (CDC) 2011. Vital Signs: Prevalence, Treatment, and Control of Hypertension United States, 1999-2002 and 2005-2008. Morbidity and Mortality weekly report, early release Vol. 60.

Choncol, M., Spiegel, D.M., 2009. The Patient With Chronic Kidney Disease, in: Schrier, RW: Manual of Nephrology Seventh Edition, pp: 185-93. Lippincott Williams & Wilkins, Philadelphia.Departemen Kesehatan RI, 1996. Kompendia Obat Bebas, in: Suryaningnorma, V.S., Fasich, Athijah, U., 2009. Analisis terhadap Faktor-Faktor yang Mempengaruhi Kepatuhan Penggunaan Obat Asma Inhalasi. Majalah Farmasi Airlangga, vol. 7 No. 1, April 2009.

Diantari, P.W., Harjaningsih, W., 2007. Evaluasi Penggunaan ACE inhibitor Pada Pasien Gagal Ginjal Kronik di RSUP Dr. Sardjito Yogyakarta. Jurnal Farmasi Indonesia. 3 (4): 189-194.Evaria, Pramudianto, A. (Eds), 2011. MIMS Edisi Bahasa Indonesia Volume 12. Bhuana Ilmu Populer, Jakarta.

Fauci, A.S., Kasper, D.L., Longo, D.L., Braunwald, E., Hauser, S.L.,Jameson, J.L., Loscalzo, J. (Eds), 2008. Harrisons Principles of Internal Medicine 17th Edition. McGraw-Hills, USA.

FK UGM, 2011. Masalah Penggunaan Obat di Institusi Pelayanan Kesehatan. Bagian Farmakologi Klinis Fakultas Kedokteran Universitas Gadjah Mada, Yogyakarta.Guyton, AC, Hall, J., 2008. Buku Ajar Fisiologi Kedokteran Edisi 11. EGC, Jakarta.

Hogan, M.J., 2007. Hypertension, in: Murphy, JG, Lloyd, MA (Eds): Mayo Clinic Cardiology Concise Textbook Third Edition, Mayo Clinic Scientific Press, USA.

Hassanien, A.A., Al-Shaikh, F., Vamos, E.P., Yadegarfar, G., Majeed, A., 2012. Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review. Journal of The Royal Society of Sports Medicine Short Reports. 3;38Ikatan Apoteker Indonesia (IAI) 2010. ISO Informasi Spesialite Obat Indonesia Volume 45. ISFI Penerbitan, Jakarta.

Jackson, E.K., 2008. Diuretik, Vasopressin dan Senyawa Lain Yang Mempengaruhi Konservasi Air di Ginjal, Renin dan Angiotensin, in: Hardman, J.G., Limbird, L.E. (Eds): Goodman & Gilman Dasar Farmakologi dan Terapi Edisi 10 Volume 1, pp: 735-85. EGC. Jakarta.Joint National Committee (JNC) 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatmentof High Blood Pressure, US Department of Health and Human Service.Kementerian Kesehatan RI 2011. Profil kesehatan Indonesia 2010. Downloaded from http://www.depkes.go.id.Katzung, B.G. (ed). 2011. Farmakologi Dasar dan Klinik Edisi 10. EGC, Jakarta.

Kidney Disease Improving Global Outcomes (KDIGO), 2012. Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Journal of International Society of Nephrology. Volume 2 issue 5.

Kumar, P., Clark, M., 2005, Clinical Medicine sixth edition. Saunders Elsevier. Philadelphia.

Llach, F., 2005. Chronic Renal Failure, in: Wilcox, S.S., Tisher, C.C., Handbook of Nephrology & Hypertension fifth Edition, Lippincott Williams & Wilkins, Philadephia.Martono, H. H., Nasution, I., Andayani, R., 2009. Penggunaan obat secara rasional pada usia lanjut, in: Pranarka, K., Martono, H. (Eds): Buku Ajar Geriatri ( Ilmu Kesehatan usia Lanjut), pp: 771-81, Balai Penerbit FKUI, Jakarta.Mitch, W.E., 2007. Chronic Kidney Disease, in: Goldman, L., Ausiello, D. (Eds): Cecil Medicine 23rd Edition, Saunders Elsevier, Philadelphia.Modlinger, P.S., Wilcox, C.S., 2005. Handbook of Nephrology and Hypertension Fifth Edition. Lippincott Williams and Wilkins. Philadephia.

Munar, M.Y., Singh, H., 2007. Drug Dosing Adjustment in Patients with Chronic Kidney Disease. Am Fam Physician. 15;75(10):1487-1496.Nafrialdi 2007. Obat Antihipertensi, in: Gunawan Sulistia (Ed): Farmakologi dan Terapi Ed.V. Departemen Farmakologi dan Terapeutik. Jakarta.

National Kidney Foundation (NKF) 2004. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease [On-line]. Available from:http://www.kidney.org/profesionals/kdoqi/guidelines_bp/index.htm.Nurwidati 2010. Evaluasi Pengobatan Pasien Pediatri Rawat Inap di Rumah Sakit Umum Daerah Dr. Moewardi Surakarta Periode 2008 (Skripsi). Universitas Muhammadiyah. Surakarta.Palmer, F.B., 2008. Hypertension and Chronic Kidney Disease (online). Available from: http://www.touchnephrology.com/articles/hypertension-and-chronic-kidney-disease.Panggabean, M.M., 2009. Penyakit Jantung Hipertensi, in: Sudoyo, AW, Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S. (Ed): Buku Ajar Ilmu Penyakit Dalam Edisi V jilid II, pp: 1777-78. Interna publishing, Jakarta.Prasetya, N.P.R., Karsana, R., Swastini, D.A., 2008. Kajian Interaksi Obat Pada Pengobatan Pasien Gagal Ginjal Kronis Hipertensi di RSUP Sanglah Denpasar Tahun 2007. Universitas Udayana, Bali.

Price, A., Wilson, M., 2012. Patofisiologi: Konsep Klinis Proses-Proses Penyakit Ed. VI. EGC, Jakarta.

Putri, R.F., 2011. Penggunaan Obat Antihipertensi Pada Pasien Dengan Penyakit Ginjal Kronis di bangsal Penyakit Dalam RSUP Dr. M. Djamil Padang (Skripsi). Universitas Andalas, Padang.Rakhim, A., 2011. Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Dengan Komplikasi di RSUD Moewardi Surakarta Tahun 2009 (Skripsi). Universitas Muhammadiyah, Surakarta.

Rani, A.A., Soegondo, S., Nasir, A.U.Z., Wijaya, I.P., Nafrialdi, Mansjoer, A. (Eds), 2006. Panduan Pelayanan Medik Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia. Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Indonesia, Jakarta. Saladin, K 2003. Anatomy and Physiology: The unity of From and Function 3rd Ed. McGraw-Hill, New York.

Santos, P.C., Krieger, J.E., Pereira, A.C., 2012. ReninAngiotensin System, Hypertension, and Chronic Kidney Disease: Pharmacogenetic Implications. J Pharmacol Sci. 120,77-88.Setiawati, A., Muchtar, A., 2007. Faktor-Faktor Yang mempengaruhi Respons Pasien terhadap Obat, in: Gunawan Sulistia (Ed): Farmakologi dan Terapi Ed.V. Departemen Farmakologi dan Terapeutik. Jakarta.Suwitra, K 2009. Penyakit Ginjal Kronik, in: Sudoyo, AW, Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S. (Ed): Buku Ajar Ilmu Penyakit Dalam Edisi V jilid II, pp: 1035-40. Interna publishing, Jakarta.Tedla, F.M., Brar, A., Browne, R., Brown, C., 2011. Hypertension in Chronic Kidney Disease: Navigating the Evidence. International Journal of Hypertension. Vol. 2011, article id 132405.

Tessy, A 2009. Hipertensi pada Penyakit Ginjal, in: Sudoyo, AW, Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S. (Ed): Buku Ajar Ilmu Penyakit Dalam Edisi V jilid II, pp: 1086-89. Interna publishing, Jakarta.World Health Organization (WHO) 2006. Guide to Good Prescribing. Geneva. (Reprinted by) Gadjah Mada University. Yogyakarta.DAFTAR PUSTAKAAnastasia, H., 2009. Situasi Demam Berdarah Dengue Di Kota Palu Sulawesi Tengah Tahun 2001-2008. Journal Of Disease Vector, Vol. III nomor 1, Juni 2009.Baskoro, A.D., Dzen, A.M., Maslamah, S., 2006. Uji Efek Larvasida Dekok Daun Pandan Wangi (Pandanus amaryllifolius) terhadap Larva Culex sp. Elibrary Brawijaya University.Boesri, H., 2011. Biologi dan Peranan Aedes albopictus (Skuse) 1894 sebagai Penular Penyakit. Balai Besar Penelitian dan Pengembangan Vektor dan Reservoir Penyakit Salatinga, Vol. 3 No 2: 117-125.Buerki, S., Callmander, M.W., Devey, D.S., Chappell, L., Gallaher, T., Munzinger, J., Haevermans, T., Forest, F., 2012. Straightening Out the Screw-Pines : a First Step in Understanding Phylogenetic Relationship Within Pandanaceae. Vol. 61 No. 5, pp:1010-1020. International Association for Plant Taxonomy.Candra, A., 2010. Demam Berdarah Dengue; Epidemiologi, Patogenesis, dan Faktor Resiko Penularan. Jurnal Penelitian Penyakit Tular Vektor, Vol.2 No.2 : 110-119.Dalimartha, S., 2005. Tanaman Obat di Lingkungan Sekitar, pp: 23. Puspa Swara: Jakarta.Departemen Kesehatan Republik Indonesia., 2000. Parameter Standar Umum Ekstrak Tumbuhan Obat. Depkes RI: Jakarta.Dinas Kesehatan, 2010. Profil Kesehatan Provinsi Sulawesi Tengah Tahun 2010. Undata: Palu.Eko, B.,2004. Metode Penelitian Kedokteran: Sebuah Pengantar. EGC: Jakarta.Endharti, A.T., Nurdiana., Thomas, J.S.P., 2011. The Potential Test of Pandan Leaves (Pandanus amaryllifolius) as an Insecticide on Aedes sp. Parasitology Laboratory Fakultas Kedokteran Universitas Brawijaya: Malang.Gunawan, D., Mulyani, S., 2004. Ilmu Obat Alam (Farmakognosi). Penebar Swadaya: Jakarta. Hariana, H.A., 2008. Tumbuhan Obat dan Khasiatnya Seri 2, pp: 164. Penebar Swadaya: Jakarta.Hidayat, S., Wahyuni, S., Andalusia, S., 2008., Seri Tumbuhan Obat Berpotensi Hias (1). PT Elex Media Komputindi: Jakarta. Lambrechts, L., Scott, T.W., Gubler, D.J., 2010. Consequences of the Expanding Global Distribution of Aedes albopictus Dengue Virus Transmission. PLOS Negleced Tropical Disease 4(5).Lestari, K., 2007. Epidemiologi dan Pencegahan Demam Berdarah Dengue (DBD) di Indonesia. Fakultas Farmasi Universitas Padjadajaran-Jatinangor, Vol.5 No.3.

Panghiyangani, R., Rahmiati., Ahda, F.N., 2009. Potensi Ekstrak Daun Dewa (Gynura Pseudochina Ldc) Sebagai Larvasida Nyamuk Aedes aegypti Vektor Penyakit Demam Berdarah Dengue. Jurnal Kedokteran Indonesia, Vol. 1 No.2. Pinheiro, P.F., Justino, G.C., 2012. Structural Analysis of Flavonoids and Related Compounds- A Review of Spectroscopic Applications. Phytochemicals- A Global Perspective of Their Role in nutrition and Health: Portugal.Prameswari, O.M., Widjanarko, S.M.Uji Efek Ekstrak Air Daun Pandan Wangi Terhadap Penurunan Kadar Glukosa Darah dan Histopatologi Tikus Diabetes Mellitus, pp 16-27. Jurnal Pangan dan Argoindustri, Vol.2 No.2.

Prasetyowati, H., 2007. Potret Insektisida Nabati Pengendali Nyamuk. Badan Litbang Kemenkes RI (Penelitian dan Pengembangan Kementerian Kesehatan Republik Indonesia). Volume II Nomor 02.Prasetyowati, H., Widawati, M.,2013. Efektifitas Ekstrak Buah Beta vulgaris L. (Buah Bit) dengan berbagai Fraksi Pelarut Terhadap Mortalitas Larva Aedes aegypti. Loka Penelitian dan Pengembangan Penyakit Bersumber Binatang (P2B2) Ciamis, Vol. 5 No. 1, pp : 23-29.Pratama, B.A., Astuti, D., Ambarwati., 2009. Pemanfaatan Ekstrak Daun Pandan Wangi (Pandanus amaryllifolius roxb) Sebagai Larvasida Alami. Fakultas Ilmu Kesehatan Universitas Muhammadiyah Surakarta. Jurnal Kesehatan, Vol. 2 No.2.Riandi, U., Ipa, M., Hendri, J., 2011. Sebaran Jentik Nyamuk Aedes spp. Di Kecamatan Tawang Kota Tasikmalaya. Loka Penelitian dan Pengembangan Pengendalian Penyakit Bersumber Binatang Ciamis: Jawa Barat. Rosa, E., Studi Tempat Perindukan Nyamuk Vektor Deman Berdarah Dengue Di Dalam dan Di Luar Rumah di RAJABASA Bandar Lampung. Jurnal Sains MIPA, Vol. 13 No. 1: 57-60. Sivanathan, M.M., 2006. Ekologi dan Biologi Aedes albopictus (skuse) (Diptera: Culicidae) dan Status Kerintangan Aedes albopictus (Strain Lapangan) Terhadap Organofosfat di Pulau Pinang, Malaysia. Tesis yang diserahkan untuk memenuhi keperluan bagi ijazah Sarjana Sains. Sugiharti, F.R., 2012. Uji Potensi Ekstrak Daun Pandan Wangi (Pandanus amaryllifolius Roxb) Sebagai Insektisida Terhadap Nyamuk Culex sp. Dewasa dengan Metode Elektrik. Tugas Akhir Program Studi Pendidikan Dokter Fakultas Kedokteran Universitas Brawijaya: Malang.Suhendro., Nainggolan, L., Chen, K., Pohan, H.T., 2009. Demam Berdarah Dengue, in: Sudoyo, AW, Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S. (Ed): Buku Ajar Ilmu Penyakit Dalam Edisi V jilid II. Interna publishing: Jakarta.Sumardjo, D., 2008. Pengantar Kimia : Buku Panduan Kuliah Mahasiswa Kedokteran dan Program Strata I Fakultas Bioeksakta. EGC: JakartaSuparjo., 2008. Saponin: Peran dan Pengaruhnya bagi Ternak dan Manusia. Karya Tulis Ilmiah. Fakultas Peternakan Universitas Jambi.Susanna, D., Rahman., Pawenang, E.T., 2003. Potensi Daun Pandan Wangi Untuk Membunuh Larva Nyamuk Aedes aegypti Larvae. Jurnal Ekologi Kesehatan, Vol. 2 No.2: 228-231.

Waji, R.A., Sugrani, A., 2009. Makalah Kimia Organik Bahan Alam Flavonoid (Quercetin). Program S2 Kimia Universitas Hasanuddin. Wakte, K.V., Nadaf, A.B., Thengane, R.J., Jawali, N., 2009. Pandanus amaryllifolius Roxb. Cultivated as a Spice in Coastal Regions of India, pp: 735-740. Genetic Resource and Crop Evolution. Vol. 56 Issues 5.World Health Organization, 2005. Panduan lengkap Pencegahan dan Pengendalian Dengue dan Demam Berdarah Dengue. EGC: Jakarta. Lampiran 1

Tests of Normalityb,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w

konsentrasiKolmogorov-SmirnovaShapiro-Wilk

StatisticDfSig.StatisticdfSig.

waktu1jam1%.1554..9984.995

kontrol positif.2524..9034.444

waktu2jam0,25%.4414..6304.001

0,5%.4414..6304.001

0,75%.2984..8494.224

1%.2374..9394.650

waktu3jam0,25%.4414..6304.001

0,5%.3074..7294.024

0,75%.2624..8604.262

1%.2524..8824.348

waktu4jam0,25%.4414..6304.001

0,5%.2834..8634.272

0,75%.1914..9794.894

1%.3004..8384.189

waktu5jam0,25%.2504..9454.683

0,5%.3824..8014.103

0,75%.3054..7894.084

1%.2504..8784.329

waktu6jam0,25%.2144..9634.798

0,5%.2714..8484.220

0,75%.1854..9934.971

1%.2914..9104.480

waktu7jam0,25%.1714..9944.976

0,5%.1854..9724.855

0,75%.3154..9114.487

1%.3124..8994.428

a. Lilliefors Significance Correction

b. waktu1jam is constant when konsentrasi = 0,25%. It has been omitted.

c. waktu1jam is constant when konsentrasi = 0,5%. It has been omitted.

d. waktu1jam is constant when konsentrasi = 0,75%. It has been omitted.

e. waktu1jam is constant when konsentrasi = kontrol negatif. It has been omitted.

f. waktu2jam is constant when konsentrasi = kontrol negatif. It has been omitted.

g. waktu2jam is constant when konsentrasi = kontrol positif. It has been omitted.

h. waktu3jam is constant when konsentrasi = kontrol negatif. It has been omitted.

i. waktu3jam is constant when konsentrasi = kontrol positif. It has been omitted.

j. waktu4jam is constant when konsentrasi = kontrol negatif. It has been omitted.

k. waktu4jam is constant when konsentrasi = kontrol positif. It has been omitted.

l. waktu5jam is constant when konsentrasi = kontrol negatif. It has been omitted.

m. waktu5jam is constant when konsentrasi = kontrol positif. It has been omitted.

n. waktu6jam is constant when konsentrasi = kontrol negatif. It has been omitted.

o. waktu6jam is constant when konsentrasi = kontrol positif. It has been omitted.

p. waktu7jam is constant when konsentrasi = kontrol negatif. It has been omitted.

q. waktu7jam is constant when konsentrasi = kontrol positif. It has been omitted.

r. jamke24 is constant when konsentrasi = 0,25%. It has been omitted.

s. jamke24 is constant when konsentrasi = 0,5%. It has been omitted.

t. jamke24 is constant when konsentrasi = 0,75%. It has been omitted.

u. jamke24 is constant when konsentrasi = 1%. It has been omitted.

v. jamke24 is constant when konsentrasi = kontrol negatif. It has been omitted.

w. jamke24 is constant when konsentrasi = kontrol positif. It has been omitted.

Tests of Normalityb,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q

konsentrasiKolmogorov-SmirnovaShapiro-Wilk

StatisticdfSig.StatisticdfSig.

wku1jam1%.2334..9594.770

kontrol positif.2634..9074.464

wku2jam1%.2204..9444.678

wku3jam1%.2634..8864.363

wku4jam1%.3034..8194.140

wku5jam1%.3074..8204.144

wku6jam1%.3454..8274.160

wku7jam1%.3534..8334.176

a. Lilliefors Significance Correction

b. There are no valid cases for wku1jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

c. There are no valid cases for wku2jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

d. wku2jam is constant when konsentrasi = kontrol positif. It has been omitted.

e. There are no valid cases for wku3jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

f. wku3jam is constant when konsentrasi = kontrol positif. It has been omitted.

g. There are no valid cases for wku4jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

h. wku4jam is constant when konsentrasi = kontrol positif. It has been omitted.

i. There are no valid cases for wku5jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

j. wku5jam is constant when konsentrasi = kontrol positif. It has been omitted.

k. There are no valid cases for wku6jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

l. wku6jam is constant when konsentrasi = kontrol positif. It has been omitted.

m. There are no valid cases for wku7jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

n. wku7jam is constant when konsentrasi = kontrol positif. It has been omitted.

o. There are no valid cases for wku24jam when konsentrasi = 1,000. Statistics cannot be computed for this level.

p. wku24jam is constant when konsentrasi = 1%. It has been omitted.

q. wku24jam is constant when konsentrasi = kontrol positif. It has been omitted.

Test Statisticsa,b

waktu1jamwaktu2jamwaktu3jamwaktu4jamwaktu5jamwaktu6jamwaktu7jamjamke24

Chi-Square22.71621.55020.91021.12921.61320.91320.70823.000

df55555555

Asymp. Sig..000.001.001.001.001.001.001.000

a. Kruskal Wallis Test

b. Grouping Variable: konsentrasi

Mann-Whitney Test

Ranks

konsentrasiNMean RankSum of Ranks

jamke240,25%46.5026.00

kontrol negatif42.5010.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U.000

Wilcoxon W10.000

Z-2.646

Asymp. Sig. (2-tailed).008

Exact Sig. [2*(1-tailed Sig.)].029a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

Ranks

konsentrasiNMean RankSum of Ranks

jamke240,5%46.5026.00

kontrol negatif42.5010.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U.000

Wilcoxon W10.000

Z-2.646

Asymp. Sig. (2-tailed).008

Exact Sig. [2*(1-tailed Sig.)].029a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

Ranks

konsentrasiNMean RankSum of Ranks

jamke240,75%46.5026.00

kontrol negatif42.5010.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U.000

Wilcoxon W10.000

Z-2.646

Asymp. Sig. (2-tailed).008

Exact Sig. [2*(1-tailed Sig.)].029a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

Ranks

konsentrasiNMean RankSum of Ranks

jamke241%46.5026.00

kontrol negatif42.5010.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U.000

Wilcoxon W10.000

Z-2.646

Asymp. Sig. (2-tailed).008

Exact Sig. [2*(1-tailed Sig.)].029a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

Ranks

konsentrasiNMean RankSum of Ranks

jamke240,25%44.5018.00

kontrol positif44.5018.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U8.000

Wilcoxon W18.000

Z.000

Asymp. Sig. (2-tailed)1.000

Exact Sig. [2*(1-tailed Sig.)]1.000a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

Ranks

konsentrasiNMean RankSum of Ranks

jamke240,5%44.5018.00

kontrol positif44.5018.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U8.000

Wilcoxon W18.000

Z.000

Asymp. Sig. (2-tailed)1.000

Exact Sig. [2*(1-tailed Sig.)]1.000a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

Ranks

konsentrasiNMean RankSum of Ranks

jamke240,75%44.5018.00

kontrol positif44.5018.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U8.000

Wilcoxon W18.000

Z.000

Asymp. Sig. (2-tailed)1.000

Exact Sig. [2*(1-tailed Sig.)]1.000a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

Ranks

konsentrasiNMean RankSum of Ranks

jamke241%44.5018.00

kontrol positif44.5018.00

Total8

Test Statisticsb

jamke24

Mann-Whitney U8.000

Wilcoxon W18.000

Z.000

Asymp. Sig. (2-tailed)1.000

Exact Sig. [2*(1-tailed Sig.)]1.000a

a. Not corrected for ties.

b. Grouping Variable: konsentrasi

55